Page last updated: 2024-08-25

rosiglitazone and Vascular Injuries

rosiglitazone has been researched along with Vascular Injuries in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, HJ; Jin, S; Kang, HJ; Kim, BK; Kim, HS; Kim, JY; Kwon, YW; Lee, HY; Lee, JE; Oh, BH; Park, YB; Yang, HM	1

Other Studies

1 other study(ies) available for rosiglitazone and Vascular Injuries

Article	Year
PPARγ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury. Experimental & molecular medicine, 2013, Nov-29, Volume: 45 Topics: Animals; Aorta; Calcium-Binding Proteins; Calponins; Cell Proliferation; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Hyperplasia; Microfilament Proteins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; PPAR gamma; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sp1 Transcription Factor; Thiazolidinediones; Thrombospondins; Tunica Intima; Vascular System Injuries	2013

Article

Year

PPARγ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury.

Experimental & molecular medicine, 2013, Nov-29, Volume: 45

Topics: Animals; Aorta; Calcium-Binding Proteins; Calponins; Cell Proliferation; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Hyperplasia; Microfilament Proteins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; PPAR gamma; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sp1 Transcription Factor; Thiazolidinediones; Thrombospondins; Tunica Intima; Vascular System Injuries

2013